Genomic analyses: A neonatology perspective

Journal of Pediatrics

Volumn 148, Issue 6, 2006, Pages 720-726

  Cotten, C Michael ^a   Ginsburg, Geoffrey S ^a   Goldberg, Ronald N ^a   Speer, Marcy C ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; SURFACTANT PROTEIN B;

ARTICLE; BRAIN HEMORRHAGE; CASE CONTROL STUDY; DATA ANALYSIS; DNA MICROARRAY; FETOPLACENTAL UNIT; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC DISORDER; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HUMAN; HYPERBILIRUBINEMIA; INFECTION; LUNG DYSPLASIA; NECROTIZING ENTEROCOLITIS; NEWBORN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; REPRODUCIBILITY; RESPIRATORY DISTRESS SYNDROME; RETROLENTAL FIBROPLASIA; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; NEONATOLOGY; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SEPSIS;

EID: 33745035661     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.01.006     Document Type: Article

References (69)

1. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., et al. Initial sequencing and analysis of the human genome. Nature 409 (2001) 860-921 Erratum in: Nature 2001;412(6846):565. Nature 2001;411:720
2. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., et al. The sequence of the human genome. Science 291 (2001) 1304-1351 Erratum in: Science 2001;292:1838
3. Guttmacher A.E., and Collins F.S. Genomic medicine. a primer. N Engl J Med 347 (2002) 1512-1520
4. Risch N. Searching for genetic determinants in the new millennium. Nature 405 (2000) 847-856
5. Van Marter L.J., Allred E.N., Pagano M., Sanocka U., Parad R., Moore M., et al., The Neonatology Committee for the Developmental Network. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease?. Pediatrics 105 (2000) 1194-1201
6. Sorensen T.I., Nielsen G.C., Anderson P.K., and Teasdale T.W. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 318 (1988) 727-732
7. Cooke G.S., and Hill A.V.S. Genetics of susceptibility to human infectious disease. Nat Rev Genet 2 (2001) 967-977
8. Farrell P.M., and Wood R.E. Epidemiology of hyaline membrane disease in the United States. analysis of national mortality statistics. Pediatrics 58 (1976) 167-176
9. Lakenau H.M. A genetic and statistical study of the respiratory distress syndrome. Eur J Pediatr 123 (1976) 167-177
10. Hallman M., Haataja R., and Marttila R. Surfactant proteins and genetic predisposition to respiratory distress syndrome. Semin Perinatol 26 (2002) 450-460
11. Bizzaro M., Shetty A., Ehrenkranz R., Ernst L., Vohr B., Desai N., et al. Familial and genetic susceptibility to major neonatal morbidities in premature twins. Soc Pediatr Res (2005) Abstract 2561. Poster presentation
12. Clark J.C., Wert S.E., Bachurski C.J., Stahlman M.T., Stripp B.R., Weaver T.E., et al. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci U S A 92 (1995) 7794-7798
13. Hellstrom A., Perruzzi C., Ju M., Engstrom E., Hard A.L., Liu J.L., et al. Low IGF-1 suppresses VEGF-survival signaling in retinal endothelial cells. direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A 98 (2001) 5404-5808
14. Cole F.S., Hamvas A., and Nogee L.M. Genetic disorders of neonatal respiratory function. Pediatr Res 50 (2001) 157-162
15. Shulenin S., Nogee L.M., Annilo T., Wert S.E., Whitsett J.A., and Dean M. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 350 (2004) 1296-1303
16. Nogee L.M., Dunbar A.E., Wert S.E., Askin F., Hamvas A., and Whitsett J.A. Brief report. a mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 344 (2001) 573-579
17. Harding D., Dhamrait S., Millar A., Humphries S., Marlow N., Whitelaw A., et al. Is interleukin-6 -174 genotype associated with the development of septicemia in preterm infants?. Pediatrics 112 (2003) 800-803
18. Kazzi S.N.J., Kim U.O., Quasney M.W., and Buhimschi I. Polymorphism of tumor necrosis factor-alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants. Pediatrics 114 (2004) e243-e248
19. Harding D., Dhamrait S., Millar A., Humphries S., Marlow N., Whitelaw A., et al. Does interleukin-6 genotype influence cerebral injury or developmental progress after preterm birth?. Pediatrics 114 (2004) 941-947
20. Ahrens P., Kattner E., Kohler B., Hartel C., Seidenberg J., Segerer H., et al. Mutations of genes involved in the innate immune system as predictors of sepsis in very low birth weight infants. Pediatr Res 55 (2004) 652-656
21. Huang M.J., Kua K.E., Teng H.C., Tang K.S., Weng H.W., and Huang C.S. Risk factors for severe hyperbilirubinemia in neonates. Pediatr Res 56 (2004) 682-689
22. Palmer L.J., and Cardon L.R. Genetic epidemiology, IV: shaking the tree: mapping complex diseases with linkage disequilibrium. Lancet 366 (2005) 1223-1234
23. Fiscella K. Race, genes and preterm birth. J Nat Med Assoc 97 (2005) 1516-1526
24. Hattersley A.T., and McCarthy M.I. Genetic epidemiology, V. what makes a good association study?. Lancet 366 (2005) 1315-1323
25. Burton P.R., Tobin M.D., and Hopper J.L. Genetic epidemiology, I. key concepts in genetic epidemiology. Lancet 366 (2005) 941-951
26. Teare M.D., and Barrett J.H. Genetic epidemiology, II. genetic linkage studies. Lancet 366 (2005) 1036-1044
27. Cordell H.J., and Clayton D.G. Genetic epidemiology, III. genetic association studies. Lancet 366 (2005) 1121-1131
28. Hopper J.L., Bishop D.T., and Easton D.F. Genetic epidemiology, VI. population-based family studies in genetic epidemiology. Lancet 366 (2005) 1397-1406
29. Davey Smith G., Ebrahim S., Lewis S., Hansell A.L., Palmer L.J., and Burton P.R. Genetic epidemiology, VII: genetic epidemiology and public health: hope, hype, and future prospects. Lancet 366 (2005) 1484-1498
30. Spielman R.S., McGinnis R.E., and Ewens W.J. Transmission test for linkage disequilibrium. the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52 (1993) 506-516
31. Haataja R., Marttila R., Uimari P., Lofgren J., Ramet M., and Hallman M. Respiratory distress syndrome. evaluation of genetic susceptibility and protection by transmission disequilibrium test. Hum Genet 109 (2001) 351-355
32. Nagourney B.A., Kramer M.S., Klebanoff M.A., and Usher R.H. Recurrent respiratory distress syndrome in successive preterm pregnancies. J Pediatr 129 (1996) 591-596
33. Nogee L.M., deMello D.E., Dehner L.P., and Colten H.R. Deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. N Engl J Med 328 (1993) 406-410
34. Nogee L.M., Wert S.E., Proffit S.A., Hull W.M., and Whitsett J.A. Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am J Respir Crit Care Med 161 (2000) 973-981
35. Cole F.S., Hamvas A., Rubinstein P., King E., Trusgnich M., Nogee L.M., et al. Population-based estimates of surfactant protein B deficiency. Pediatrics 105 (2000) 538-541
36. Haataja R., Ramet M., Marttila R., and Hallman M. Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome. Hum Mol Genet 9 (2000) 2751-2760
37. Karinch A.M., deMello D.E., and Floros J. Effect of genotype on the levels of surfactant protein-A mRNA and on the SP-A2 splice variants in adult humans. Biochem J 321 (1997) 39-47
38. deMello D.E., Phelps D.S., Patel G., Floros J., and Lagunoff D. Expression of the 35-kDa and low molecular weight surfactant-associated proteins in the lungs of the infants dying with respiratory distress syndrome. Am J Pathol 134 (1989) 1285-1293
39. Hallman M., Merritt T.A., Akino T., and Bry K. Surfactant protein A, phophatidylcholine, and surfactant inhibitors in epithelial lining fluid. correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants. Am Rev Respir Dis 144 (1991) 1376-1384
40. Ramet M., Haataja R., Marttila R., Floros J., and Hallman M. Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population. Am J Hum Genet 66 (2000) 1569-1579
41. Martilla R., Haataja R., Guttentag S., and Hallman M. Surfactant protein A and B genetic variants in respiratory distress syndrome in singletons and twins. Am J Respir Crit Care Med 168 (2003) 1216-1222
42. Cockshutt A.M., Weitz J., and Possmayer F. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 29 (1990) 8424-8429
43. Venkitaraman A.R., Hall S.B., Whitsett J.A., and Notter R.H. Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A. Chem Physiol Lipids 56 (1990) 185-194
44. Rova M., Haataja R., Marttila R., Ollikainen V., Tammela O., and Hallman M. Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia. Hum Mol Genet 13 (2004) 1095-1104
45. Stoll B.J., Hansen N.I., Adams-Chapman I., Fanaroff A.A., Hintz S.R., Vohr B., et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 292 (2004) 2357-2365
46. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., et al. Late-onset sepsis in very low birth weight neonates. the experience of the NICHD Neonatal Research Network. Pediatrics 110 (2002) 285-291
47. NIH web site: http:/privacyruleandresearch.nih.gov/pdf/research_repositories_final.pdf .
48. Hirshhorn J.N., Lohmuller K., Byrne E., and Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 4 (2002) 45-61
49. Ioannidis J.N., Ntzani E.E., Trikalinos T.A., and Contopouos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet 29 (2001) 306-309
50. Ioannidis J.P.A., Trikalinos T.A., Ntzani E.E., and Contopoulos-Ioannidis D.G. Genetic associations in large versus small studies. an empirical assessment. Lancet 361 (2003) 567-571
51. Silverman E.K., and Palmer L.J. Case-control association studies for the genetics of complex respiratory diseases. Am J Respir Cell Mol Biol 22 (2000) 645-648
52. Lohmuller K.E., Pearce C.L., Pike M., Lander E.S., and Hirshhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33 (2003) 177-182
53. Whitsett J.A., and Weaver T.E. Mechanisms of disease. hydrophobic surfactant proteins in lung function and disease. N Engl J Med 347 (2002) 2141-2148
54. Lemons J.A., Bauer C.R., Oh W., Korones S.B., Papile L., Stoll B.J., et al. Very-low-birth-weight outcomes of the NICHD Neonatal Research Network, January 1995 through December 1996. Pediatrics 107 (2001) e1
55. Jobe A.H., and Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163 (2001) 1723-1729
56. Walsh M.C., Yao Q., Gettner P., Hale E., Collins M., Hensman A., et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics 114 (2004) 1305-1311
57. Ellsbury D.L., Acarregui M.J., McGuinness G.A., and Klein J.M. Variability in the use of supplemental oxygen for bronchopulmonary dysplasia. J Pediatr 140 (2002) 247-249
58. Ginsburg G.S., Donahue M., and Newby K.L. Prospects for personalized cardiovascular medicine. the impact of genomics. J Am Coll Cardiol 46 (2005) 1615-1627
59. Shorck N. Genetics of complex disease, approaches, problems and solutions. Am J Respir Crit Care Med 156 (1997) S103-S109
60. Bentley D.R. Genomes for medicine. Nature 429 (2004) 440-445
61. Meyer J.M., and Ginsburg G.S. The path to personalized medicine. Curr Opin Chem Biol 6 (2002) 434-438
62. Snyderman R., and Williams R.S. Prospective medicine. the next health care transformation. Acad Med 78 (2003) 1079-1084
63. Mariadason J.M., Augenlicht L.H., and Arango D. Microarray analysis in the clinical management of cancer. Hematol Oncol Clin North Am 17 (2003) 377-387
64. Rees-Unwin K.S., Morgan G.J., and Davies F.E. Proteomics and the haematologist. Clin Lab Haematol 26 (2004) 77-86
65. Weston A.D., and Hood L. Systems biology, proteomics, and the future of health care. toward predictive preventative, and personalized medicine. J Proteome Res 3 (2004) 179-196
66. Gravett M.G., Novy M.J., Rosenfeld R.G., Reddy A.P., Jacob T., Turner M., et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 292 (2004) 462-469
67. Hirsch J., Hansen K.C., Burlingame A.L., and Matthay M.A. Proteomics. current techniques and potential applications to lung disease. Am J Physiol Lung Cell Mol Physiol 287 (2004) L1-L23
68. Gibney M.J., Walsh M., Brennan L., Roche H.M., German B., and van Ommen B. Metabolomics in human nutrition. opportunities and challenges. Am J Clin Nutr 82 (2005) 497-503
69. Martin J.A., Kochanek K.K., Strobino D.M., Guyer B., and MacDorman M.F. Annual summary of vital statistics. 2003. Pediatrics 115 (2005) 619-634